| magnesium citrate | No effect - effects | arterial stiffness | Human | healthy overweight and slightly obese men and women | — | Effects of magnesium citrate, magnesium oxide and magnesium sulfate supplementation on arterial stiffness in healthy overweight individuals: a study protocol for a randomized controlled trial.cited 6× |
| magnesium oxide | No effect - effects | arterial stiffness | Human | healthy overweight and slightly obese men and women | — | Effects of magnesium citrate, magnesium oxide and magnesium sulfate supplementation on arterial stiffness in healthy overweight individuals: a study protocol for a randomized controlled trial.cited 6× |
| magnesium citrate supplementation | Decreases - results in a clinically relevant improvement | arterial stiffness | Human | — | — | Effects of magnesium citrate, magnesium oxide and magnesium sulfate supplementation on arterial stiffness in healthy overweight individuals: a study protocol for a randomized controlled trial.cited 6× |
| magnesium sulfate | No effect - effects | arterial stiffness | Human | healthy overweight and slightly obese men and women | — | Effects of magnesium citrate, magnesium oxide and magnesium sulfate supplementation on arterial stiffness in healthy overweight individuals: a study protocol for a randomized controlled trial.cited 6× |
| oral magnesium supplementation | Decreases - can improve | arterial stiffness and calcification propensity | Human | patients with stage 3-4 CKD | Not specified in the abstract. | Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease.cited 6× |
| oral magnesium supplementation with additional phosphate-binding therapy | Decreases - can improve | arterial stiffness and calcification propensity | Human | patients with stage 3-4 CKD | Not specified in the abstract. | Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease.cited 6× |
| magnesium citrate supplementation | Decreases - aims to modulate | the complex and deregulated mineral metabolism leading to vascular calcification and arterial stiffness | Human | stage 3-4 CKD patients without overt hyperphosphatemia | Not specified in the abstract. | Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease.cited 6× |
| daily magnesium supplement of 350 mg for 24 wk | Decreases - reduces | arterial stiffness | Human | overweight and obese adults | 350 mg/d (3 × 117 mg daily). | Long-term magnesium supplementation improves arterial stiffness in overweight and obese adults: results of a randomized, double-blind, placebo-controlled intervention trial.cited 62× |
| magnesium supplementation | No effect - without effect | arterial stiffness parameters | Human | thiazide-treated hypertensive women | 600 mg/day (magnesium chelate) | Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women.cited 45× |
| Long-term magnesium supplementation | Decreases - improves | arterial stiffness | Human | — | 350 mg daily (three times daily dosing). | Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: A randomized controlled trial in overweight/obese adults.cited 31× |
| magnesium oxide | No effect - had similar nonsignificant effects | arterial stiffness | Human | subjects who were overweight and slightly obese | 450 mg/d (total daily dose). | Effects of Magnesium Citrate, Magnesium Oxide, and Magnesium Sulfate Supplementation on Arterial Stiffness: A Randomized, Double-Blind, Placebo-Controlled Intervention Trial.cited 11× |
| magnesium citrate supplementation | No effect - did not significantly change | arterial stiffness | Human | subjects who were overweight and slightly obese | 450 mg/d (total daily dose). | Effects of Magnesium Citrate, Magnesium Oxide, and Magnesium Sulfate Supplementation on Arterial Stiffness: A Randomized, Double-Blind, Placebo-Controlled Intervention Trial.cited 11× |
| magnesium sulfate | No effect - had similar nonsignificant effects | arterial stiffness | Human | subjects who were overweight and slightly obese | 450 mg/d (total daily dose). | Effects of Magnesium Citrate, Magnesium Oxide, and Magnesium Sulfate Supplementation on Arterial Stiffness: A Randomized, Double-Blind, Placebo-Controlled Intervention Trial.cited 11× |
